Trademark Overview
On Monday, June 23, 2025, a trademark application was filed for BRISTAR with the United States Patent and Trademark Office. The USPTO has given the BRISTAR trademark a serial number of 99247300. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 9, 2025. This trademark is owned by BRISTAR IMMUNOTECH LIMITED. The BRISTAR trademark is filed in the Pharmaceutical Products category with the following description:
Biological preparations for the treatment of cancer; medicines for human purposes for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system, including T-cell therapy; Living cells for medical use; drugs for medical purposes, namely, medicines for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system，including T-cell Therapy; pharmaceutical preparations for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system, including T-cell therapy; biological preparations for medical purposes for the treatment of cancer, hematological tumors, solid tumors, autoimmune diseases, and regulation of the immune system, including T-cell therapy; Cellular function activating agents for medical purposes; pharmaceutical preparations for the prevention of cancer; pharmaceutical preparations for the treatment of cancer
